Clinical Trials Directory

Trials / Unknown

UnknownNCT02862483

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
IlDong Pharmaceutical Co Ltd · Industry
Sex
Male
Age
45 Years
Healthy volunteers
Not accepted

Summary

The efficacy and safety of the combination of tamsulosin and tadalafil in men with lower urinary tract symptoms due to benign prostatic hyperplasia and Erectile Dysfunction: a randomized, double blinded, parallel design, active controlled, multi-center, phase 3 clinical trial

Conditions

Interventions

TypeNameDescription
DRUGTamsulosin 0.2mg
DRUGTadalafil 5mg
DRUGPlacebo for Tamsulosin

Timeline

Start date
2016-03-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-08-11
Last updated
2016-08-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02862483. Inclusion in this directory is not an endorsement.

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to B (NCT02862483) · Clinical Trials Directory